Rituximab therapy for life-threatining immune hemolytic anemia in a liver tranplant recipient: a case report (Q80335952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Rituximab therapy for life-threatining immune hemolytic anemia in a liver tranplant recipient: a case report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Akyildiz M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Karasu Z

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Cagirgan S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tokat Y

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1492-1493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Use of rituximab, the new FDA-approved antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Severe Evans's syndrome secondary to interleukin-2 therapy: treatment with chimeric monoclonal anti-CD20 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Treatment of childhood autoimmune haemolytic anaemia with rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Donor anti-Jk(a) causing hemolysis in a liver transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.05.042

10.1016/J.TRANSPROCEED.2004.05.042

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15251367%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference